Aibeta® BAC-free formulation
Glaucoma/Ocular Hypertension
ApprovedActive
Key Facts
About Senju Pharmaceutical
Senju Pharmaceutical is a long-established, specialized ophthalmology company with a global footprint, headquartered in Japan and operating in Fort Worth, USA. It has a diversified portfolio spanning prescription drugs, OTC products, and a robust R&D pipeline targeting conditions like dry eye disease and glaucoma. The company demonstrates commercial execution through recent product approvals and strategic licensing agreements, positioning it in the growing global eye care market.
View full company profileTherapeutic Areas
Other Glaucoma/Ocular Hypertension Drugs
| Drug | Company | Phase |
|---|---|---|
| Glaucoma Studies | Oculus Research | Not Applicable (Service Provider) |
| Bimatoprost Sustained-Release | Galderma Group | Phase 3 |